MeSH term
Frequency | Condition_Probility | Carcinoma/*genetics | 3 | 2.0 |
Chromosomes, Human, Pair 12/*genetics | 5 | 4.0 |
Comparative Study | 9 | 0.0 |
DNA, Neoplasm/genetics | 5 | 0.0 |
Gene Amplification/*genetics | 3 | 2.0 |
Gene Expression Regulation, Neoplastic/genetics | 2 | 1.0 |
Humans | 62 | 0.0 |
In Situ Hybridization, Fluorescence/methods | 2 | 2.0 |
Nucleic Acid Hybridization | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 49 | 0.0 |
Tumor Cells, Cultured | 10 | 0.0 |
Adolescent | 4 | 0.0 |
Adult | 9 | 0.0 |
Base Sequence | 12 | 0.0 |
Child | 2 | 0.0 |
Chromosome Banding | 3 | 0.0 |
Female | 27 | 0.0 |
In Situ Hybridization, Fluorescence | 6 | 0.0 |
Karyotyping | 5 | 0.0 |
Male | 25 | 0.0 |
Middle Aged | 14 | 0.0 |
Genotype | 4 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 11 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 21 | 0.0 |
Alleles | 7 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics/metabolism | 2 | 1.0 |
Transfection | 2 | 0.0 |
Mice | 14 | 0.0 |
Cell Division | 2 | 0.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Genes, p53/genetics | 2 | 0.0 |
Mutation | 8 | 0.0 |
Polymerase Chain Reaction | 15 | 0.0 |
Proto-Oncogene Proteins/genetics | 8 | 1.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Animals | 19 | 0.0 |
Genes, ras | 5 | 2.0 |
Genes, p53 | 4 | 0.0 |
Ovarian Neoplasms/*genetics | 2 | 0.0 |
DNA/metabolism | 2 | 0.0 |
*Mutation | 11 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
Chromosome Disorders | 2 | 0.0 |
Adenocarcinoma/*genetics | 4 | 2.0 |
Genetic Markers | 7 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Lung Neoplasms/*genetics | 9 | 3.0 |
DNA Primers | 3 | 0.0 |
*Genes, p53 | 2 | 0.0 |
*Genes, ras | 10 | 4.0 |
Neoplasms/*genetics | 2 | 0.0 |
Proto-Oncogene Proteins B-raf | 5 | 7.0 |
Adenoma/*genetics | 4 | 4.0 |
*Chromosome Mapping | 3 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Linkage (Genetics) | 4 | 0.0 |
Genes, p53/*genetics | 2 | 0.0 |
Prognosis | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Deoxyribonucleases, Type II Site-Specific/metabolism | 3 | 1.0 |
Aged | 11 | 0.0 |
Microsatellite Repeats/genetics | 2 | 0.0 |
Chromosome Mapping | 14 | 0.0 |
*Chromosomes, Human, Pair 12 | 9 | 3.0 |
*Gene Amplification | 4 | 1.0 |
Germinoma/*genetics | 2 | 14.0 |
Testicular Neoplasms/*genetics | 2 | 8.0 |
Pedigree | 2 | 0.0 |
Carcinogens | 2 | 2.0 |
Exons | 2 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Protein p16/genetics | 2 | 2.0 |
DNA, Neoplasm/*genetics | 2 | 0.0 |
Base Pair Mismatch/genetics | 2 | 4.0 |
Neoplasm Staging | 3 | 0.0 |
Proto-Oncogene Proteins c-raf/*genetics | 2 | 5.0 |
Aged, 80 and over | 5 | 0.0 |
Colorectal Neoplasms/*genetics | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Species Specificity | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Genetic Predisposition to Disease/genetics | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Mutation/genetics | 3 | 0.0 |
Genes, ras/*genetics | 6 | 6.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Chromosome Aberrations | 2 | 0.0 |
*Oncogenes | 4 | 0.0 |
Parathyroid Hormone-Related Protein | 2 | 2.0 |
Proteins/*genetics | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/*genetics | 2 | 1.0 |
DNA Mutational Analysis | 3 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Blotting, Southern | 4 | 0.0 |
Hybrid Cells | 2 | 0.0 |
DNA Probes | 5 | 0.0 |
*Polymorphism, Restriction Fragment Length | 5 | 0.0 |
Chromosomes, Human, Pair 12 | 2 | 1.0 |
Deoxyribonucleases, Type II Site-Specific | 2 | 0.0 |
Codon/genetics | 3 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Gene Amplification | 3 | 0.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Metaphase | 2 | 1.0 |
Tumor Markers, Biological/*blood | 2 | 0.0 |
